PC
LJPC

PointState Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

PointState Capital’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-184,360
Closed -$3.23M – 182
2016
Q4 		$3.23M Sell
184,360
-15,640
-8% -$300K 0.05% 102
2016
Q3 		$4.76M Buy
+200,000
New +$3.77M 0.05% 106

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

PointState Capital's LJPC Position: Q1 2017 in Review

PointState Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2017, closing a stake of 184,360 shares — an estimated $3.23M sold.

PointState Capital first reported a position in LJPC in Q3 2016 and held it in 2 quarters. The position peaked at $4.76M in Q3 2016. 96 funds tracked by Wall St. Rank hold LJPC as of Q1 2017.

  • PointState Capital reported no remaining La Jolla Pharmaceutical Company position as of Q1 2017 after selling out during the quarter.
  • PointState Capital sold 184,360 La Jolla Pharmaceutical Company shares in Q1 2017, an estimated $3.23M.
  • PointState Capital first reported a position in La Jolla Pharmaceutical Company in Q3 2016 and held it in 2 quarters.
  • PointState Capital's La Jolla Pharmaceutical Company position peaked at $4.76M in Q3 2016.
  • 96 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2017.

Based on PointState Capital's 13F filing for Q1 2017, filed 15 May 2017.